4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-038582
Chief Development Officer sold 5,887 shares at an average $15.04 ($88,565)
- Chief Development Officer acquired 4,687 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Curley Joanne · Chief Development Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-17 | Exercise or conversion : show line 1 in the form | +1,346 | $6.37 | $8,578 | 26,540 | D |
| 2022-06-17 | Sale : show line 2 in the form | −1,346 | $15.08 | $20,294 | 25,194 | D |
| 2022-06-17 | Exercise or conversion : show line 3 in the form | +3,341 | $2.90 | $9,678 | 28,535 | D |
| 2022-06-17 | Sale : show line 4 in the form | −3,341 | $15.03 | $50,211 | 25,194 | D |
| 2022-06-17 | Sale : show line 5 in the form | −1,200 | $15.05 | $18,061 | 23,994 | D |
| Open-market sales · 5,887 sh · avg $15.04 · $88,565 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-17 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −1,346 | 24,145 | D |
| 2022-06-17 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −3,341 | 62,681 | D |
Loading xslF345X03/doc4.xml…